NMC
NEA Management Company Portfolio holdings
AUM
$1.33B
This Quarter Return
+17.55%
1 Year Return
+85.82%
3 Year Return
+531.37%
5 Year Return
+304.32%
10 Year Return
+4,927.96%
AUM
$1.45B
AUM Growth
+$1.45B
(-19%)
Cap. Flow
-$207M
Cap. Flow
% of AUM
-14.28%
Top 10 Holdings %
Top 10 Hldgs %
62.93%
Holding
58
New
1
Increased
5
Reduced
10
Closed
5
Top Buys
| 1 |
Geron
GERN
|
$10.9M |
| 2 |
UTRS
Minerva Surgical, Inc. Common Stock
UTRS
|
$4.83M |
| 3 |
ADXN
Addex Therapeutics
ADXN
|
$900K |
| 4 |
Senti Biosciences
SNTI
|
$287K |
| 5 |
Wheels Up
UP
|
$29K |
Top Sells
| 1 |
OYST
Oyster Point Pharma, Inc. Common Stock
OYST
|
$66.2M |
| 2 |
Cloudflare
NET
|
$38.5M |
| 3 |
Rhythm Pharmaceuticals
RYTM
|
$35.7M |
| 4 |
Coursera
COUR
|
$34.6M |
| 5 |
BILL Holdings
BILL
|
$6.84M |
Sector Composition
| 1 | Healthcare | 67.32% |
| 2 | Technology | 13.44% |
| 3 | Consumer Staples | 10.25% |
| 4 | Industrials | 7.8% |
| 5 | Communication Services | 1.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Celcuity
CELC
$2.3B
| $12.8M | 0.89% |
1,250,001
| – | – |
|
27
Nkarta
NKTX
$149M
| $12.7M | 0.88% |
3,568,781
| – | – |
|
28
X4 Pharmaceuticals
XFOR
$70M
| $10.2M | 0.71% |
11,736,793
| – | – |
|
|
TUYA
29
Tuya Inc
TUYA
$1.54B
| $9.33M | 0.64% |
4,934,640
| – | – |
|
30
Champions Oncology
CSBR
$95.8M
| $6.89M | 0.48% |
1,713,720
| – | – |
|
|
UTRS
31
DELISTED
Minerva Surgical, Inc. Common Stock
UTRS
| $6.8M | 0.47% |
34,437,052
+24,437,927
| +244% | +$4.83M |
|
32
Black Diamond Therapeutics
BDTX
$164M
| $6.52M | 0.45% |
3,448,757
| – | – |
|
|
CBIO
33
Crescent Biopharma, Inc. Common Stock
CBIO
$184M
| $6M | 0.42% |
4,764,440
-4,203,266
| -47% | -$5.3M |
|
34
Lexicon Pharmaceuticals
LXRX
$392M
| $5.79M | 0.4% |
2,382,286
| – | – |
|
|
IVA
35
Inventiva
IVA
$802M
| $4.99M | 0.35% |
1,462,586
| – | – |
|
|
36
Senti Biosciences
SNTI
$37.9M
| $4.92M | 0.34% |
4,700,385
+274,234
| +6% | +$287K |
|
37
Acrivon Therapeutics
ACRV
$42.2M
| $4.89M | 0.34% |
481,677
| – | – |
|
38
Gossamer Bio
GOSS
$587M
| $4.37M | 0.3% |
3,467,406
| – | – |
|
|
AFMD
39
DELISTED
Affimed
AFMD
| $3.3M | 0.23% |
4,426,488
| – | – |
|
40
Synlogic
SYBX
$17.4M
| $2.67M | 0.18% |
4,228,940
| – | – |
|
|
STSA
41
DELISTED
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
| $1.6M | 0.11% |
2,294,095
-698,863
| -23% | -$488K |
|
|
RGLS
42
DELISTED
Regulus Therapeutics
RGLS
| $1.22M | 0.08% |
1,445,114
| – | – |
|
|
ADXN
43
Addex Therapeutics
ADXN
$8.65M
| $1.11M | 0.08% |
5,648,690
+4,568,690
| +423% | +$900K |
|
|
EAR
44
DELISTED
Eargo, Inc. Common Stock
EAR
| $1.06M | 0.07% |
226,000
-4,294,198
| -95% | -$47 |
|
|
MIMO
45
DELISTED
Airspan Networks Holdings Inc.
MIMO
| $941K | 0.07% |
1,359,842
-22,458
| -2% | -$15.5K |
|
46
Marker Therapeutics
MRKR
$11.2M
| $761K | 0.05% |
1,071,428
-9,642,857
| -90% | -$1 |
|
|
47
Wheels Up
UP
$1.63B
| $682K | 0.05% |
1,108,371
+47,112
| +4% | +$29K |
|
48
FiscalNote
NOTE
$66.2M
| $576K | 0.04% |
307,344
-1,386,979
| -82% | -$2.6M |
|
|
OBSV
49
DELISTED
ObsEva SA Ordinary Shares
OBSV
| $500K | 0.03% |
4,586,563
| – | – |
|
|
AKTX
50
Akari Therapeutics
AKTX
$21.4M
| $82.2K | 0.01% |
452,167
| – | – |
|